Endotronix

About:

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.

Website: http://www.endotronix.com

Twitter/X: endotronix

Top Investors: JumpStart, Silicon Valley Bank, EQT Life Sciences, SV Health Investors, OSF Ventures

Description:

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.

Total Funding Amount:

$130M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lisle, Illinois, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)endotronix.com

Founders:

Anthony I. Nunez, Harry D. Rowland

Number of Employees:

51-100

Last Funding Date:

2018-09-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai